New study to monitor pregnancies in organ transplant recipients
NCT ID NCT07592806
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 2,000 women in France who have had a solid organ transplant and become pregnant. Researchers will track pregnancy outcomes and complications like preeclampsia for up to one year after delivery. The goal is to gather standardized data to improve counseling and care for transplant recipients considering pregnancy.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide clear, up-to-date information to help doctors and couples plan and manage pregnancies after organ transplants.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test any new therapy, so it cannot directly improve health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 2,000 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2036
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 48 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female patient aged 18 years or older and of childbearing age * Has received a solid organ transplant, either isolated or combined (heart, liver, lung, pancreas, kidney) * Has a positive blood beta-hCG test result \> 5 IU/L ("positive") * Has signed an informed consent form * Affiliated with a health insurance plan Exclusion Criteria: * Patient deprived of liberty or under legal guardianship * Patient refuses to participate in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Surgical operation with transplant of whole organ are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.